Guerrero-Wyss, MarionYans, CarolineBoscán-González, ArturoDuran, PabloParra-Soto, SolangeAngarita, Lissé2023-08-082023-08-082023-07International Journal of Molecular Sciences, Volume 24, Issue 13, July 2023, Article number 1077916616596https://repositorio.unab.cl/xmlui/handle/ria/52305Indexación: ScopusDurvillaea antarctica is the seaweed that is the most consumed by the Chilean population. It is recognized worldwide for its high nutritional value in protein, vitamins, minerals, and dietary fiber. This is a narrative review in which an extensive search of the literature was performed to establish the immunomodulator, cardiometabolic, and gut microbiota composition modulation effect of Durvillaea antarctica. Several studies have shown the potential of Durvillaea antarctica to function as prebiotics and to positively modulate the gut microbiota, which is related to anti-obesity, anti-inflammatory, anticancer, lipid-lowering, and hypoglycemic effects. The quantity of Bacteroides was negatively correlated with that of inflammatory monocytes and positively correlated with the levels of several gut metabolites. Seaweed-derived polysaccharides modulate the quantity and diversity of beneficial intestinal microbiota, decreasing phenol and p-cresol, which are related to intestinal diseases and the loss of intestinal function. Additionally, a beneficial metabolic effect related to this seaweed was observed, mainly promoting the decrease in the glycemic levels, lower cholesterol levels and cardiovascular risk. Consuming Durvillaea antarctica has a positive impact on the immune system, and its bioactive compounds provide beneficial effects on glycemic control and other metabolic parameters. © 2023 by the authors.encardiovascular riskDurvillaea antarcticametabolic syndromemicrobiotaseaweedArtículoAttribution 4.0 International (CC BY 4.0)10.3390/ijms241310779